Alvotech (ALVO) vs SELLAS Life Sciences Group, Inc. (SLS)

A side-by-side comparison of Alvotech and SELLAS Life Sciences Group, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Alvotech logo
ALVO
Alvotech
$2.09B
$6.17HealthcareDelayed quote: Oct 6, 2026, 3:20 PM EDT
SELLAS Life Sciences Group, Inc. logo
SLS
SELLAS Life Sciences Group, Inc.
$2.13B
$11.43HealthcareDelayed quote: Oct 6, 2026, 3:15 PM EDT

Total return — ALVO vs SLS

growth of $100 · dividends reinvested · last 4y
ALVO -45.4% (-14.0%/yr)SLS +388.6% (+48.7%/yr)SLS compounded faster over this window
Log scale — wide-divergence pair
101001kStart $1002023202420252026$55$489
ALVO SLS

ALVO vs SLS: by the numbers

  • •SLS is the larger company ($2.13B vs $2.09B market cap).
  • •Both run net losses; SLS's is the smaller (0.00% vs -36.51% net margin).

Metrics side by side

Valuation

MetricALVOSLS
P/S ratio4.24N/A
P/B ratioN/A15.44
EV / EBITDA42.07N/A

Profitability

MetricALVOSLS
Gross margin60.45%0.00%
Operating margin9.62%0.00%
Net margin-36.51%0.00%
ROEN/A-23.58%
ROIC3.61%-25.45%

Growth (annualized)

MetricALVOSLS
Revenue CAGR (5Y)69.03%N/A
Total return CAGR (5Y)N/A6.20%

Go deeper

Full ALVO analysisFull SLS analysisInteractive comparison tool

Dig into the metrics

Alvotech ROESELLAS Life Sciences ROEAlvotech operating marginSELLAS Life Sciences operating marginAlvotech revenue growthSELLAS Life Sciences revenue growthAlvotech free cash flowSELLAS Life Sciences free cash flow

Alvotech & SELLAS Life Sciences appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.